| Primary |
| Small Intestine Carcinoma |
16.7% |
| Colon Cancer |
11.1% |
| Gastrointestinal Carcinoma |
11.1% |
| Metastatic Gastric Cancer |
11.1% |
| Product Used For Unknown Indication |
11.1% |
| Bowel Cancer |
5.6% |
| Chemotherapy |
5.6% |
| Colon Cancer Recurrent |
5.6% |
| Colorectal Cancer |
5.6% |
| Malignant Neoplasm Of Ampulla Of Vater |
5.6% |
| Metastases To Lung |
5.6% |
| Rectal Cancer |
5.6% |
|
| Shock |
16.7% |
| Bone Marrow Failure |
8.3% |
| Cold Sweat |
8.3% |
| Hyperbilirubinaemia |
8.3% |
| Loss Of Consciousness |
8.3% |
| Neutropenia |
8.3% |
| Neutropenic Sepsis |
8.3% |
| Post Procedural Complication |
8.3% |
| Respiratory Failure |
8.3% |
| Thrombotic Thrombocytopenic Purpura |
8.3% |
| Unresponsive To Stimuli |
8.3% |
|
| Secondary |
| Colon Cancer |
32.2% |
| Colorectal Cancer Metastatic |
23.5% |
| Colorectal Cancer |
20.5% |
| Gastric Cancer |
5.1% |
| Adenocarcinoma Pancreas |
4.6% |
| Pancreatic Carcinoma |
3.3% |
| Rectal Cancer |
1.9% |
| Pancreatic Neoplasm |
1.5% |
| Gallbladder Cancer |
1.3% |
| Adenocarcinoma |
0.8% |
| Gastrooesophageal Cancer |
0.8% |
| Pancreatic Carcinoma Metastatic |
0.8% |
| Diffuse Large B-cell Lymphoma |
0.7% |
| Colon Cancer Metastatic |
0.6% |
| Neuroendocrine Carcinoma |
0.5% |
| Product Used For Unknown Indication |
0.5% |
| Insulinoma |
0.4% |
| Malignant Neoplasm Of Islets Of Langerhans |
0.3% |
| Metastases To Liver |
0.3% |
| Metastatic Colorectal Cancer |
0.3% |
|
| Vomiting |
25.8% |
| Pyrexia |
13.4% |
| White Blood Cell Count Decreased |
8.1% |
| White Blood Cell Count Increased |
4.8% |
| Neutropenia |
4.3% |
| Weight Decreased |
4.3% |
| Thrombocytopenia |
3.8% |
| Ventricular Extrasystoles |
3.8% |
| Diarrhoea |
3.2% |
| Renal Failure |
3.2% |
| Renal Failure Acute |
3.2% |
| Haemorrhoids |
2.7% |
| Oesophagitis |
2.7% |
| Small Intestinal Obstruction |
2.7% |
| Stent Occlusion |
2.7% |
| Syncope |
2.7% |
| Gastric Ulcer |
2.2% |
| Hypoaesthesia |
2.2% |
| Pneumonia |
2.2% |
| Sepsis |
2.2% |
|
| Concomitant |
| Colorectal Cancer Metastatic |
32.0% |
| Colon Cancer |
22.7% |
| Colorectal Cancer |
10.3% |
| Colon Cancer Metastatic |
4.1% |
| Prophylaxis Of Nausea And Vomiting |
4.1% |
| Colon Cancer Stage Iii |
3.1% |
| Drug Use For Unknown Indication |
3.1% |
| Pancreatic Carcinoma |
3.1% |
| Rectal Cancer |
3.1% |
| Breast Cancer Metastatic |
2.1% |
| Ill-defined Disorder |
2.1% |
| Non-small Cell Lung Cancer |
2.1% |
| Breast Cancer |
1.0% |
| Colorectal Cancer Stage Iii |
1.0% |
| Gastric Cancer |
1.0% |
| Hepatic Cancer Stage Iv |
1.0% |
| Neuroendocrine Carcinoma Metastatic |
1.0% |
| Non-hodgkin's Lymphoma |
1.0% |
| Oesophageal Carcinoma |
1.0% |
| Pancreatic Carcinoma Metastatic |
1.0% |
|
| Proteinuria |
11.4% |
| Jaundice |
8.6% |
| Blood Bilirubin Increased |
5.7% |
| Gastrointestinal Perforation |
5.7% |
| Hypersensitivity |
5.7% |
| Hypoxia |
5.7% |
| Infusion Related Reaction |
5.7% |
| Pulmonary Embolism |
5.7% |
| Rash |
5.7% |
| Vision Blurred |
5.7% |
| Vomiting |
5.7% |
| Weight Decreased |
5.7% |
| Abdominal Pain |
2.9% |
| Anaphylactic Shock |
2.9% |
| Cardiotoxicity |
2.9% |
| Colorectal Cancer Stage Iv |
2.9% |
| Coronary Artery Thrombosis |
2.9% |
| Diarrhoea |
2.9% |
| Disease Progression |
2.9% |
| Diverticulitis |
2.9% |
|
